Drug intelligence / Profile preview

sincalide

Development stage
Approved
Lead developer
Ferring Pharmaceuticals
Modality
Small Molecules, Peptides
Administration
Intravenous
01

Overview

Sincalide is a synthetic peptide that corresponds to the C-terminal octapeptide of the naturally occurring hormone cholecystokinin (CCK). It acts as a diagnostic agent primarily used to stimulate gallbladder contraction and pancreatic secretion during diagnostic imaging or laboratory analysis. Sincalide is administered intravenously and mimics endogenous cholecystokinin by causing the gallbladder to contract, leading to bile evacuation similar to physiological processes. It also stimulates pancreatic secretion of bicarbonate and digestive enzymes, especially when combined with secretin. Additionally, sincalide accelerates intestinal transit of barium meals during radiological examinations, reducing radiation exposure time. Its main indications are for use in adults undergoing tests for gallbladder function (e.g., imaging or duodenal aspiration), assessment of pancreatic exocrine function (with secretin), and speeding up barium meal transit through the small intestine[1][2][4][5][6][7][8]. **Developers:** Ferring Pharmaceuticals **Manufacturers:** Ferring Pharmaceuticals, AVIR Pharma

Brand names
Kinevac
Other names
sincalidecholecystokinin octapeptidesynthetic cholecystokinin octapeptide
02

Targets

CCKAR (Cholecystokinin A receptor)CCK2R (Cholecystokinin 2 Receptor)

Beyond the preview

Go deeper on sincalide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sincalide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call